Xu W, Zhang S, Qin H, Yao K
J Transl Med. 2024; 22(1):1133.
PMID: 39707395
PMC: 11662623.
DOI: 10.1186/s12967-024-05957-3.
Holubowicz R, Du S, Felgner J, Smidak R, Choi E, Palczewska G
Nat Biomed Eng. 2024; 9(1):57-78.
PMID: 39609561
PMC: 11754100.
DOI: 10.1038/s41551-024-01296-2.
Oh D
Glob Med Genet. 2024; 11(4):319-329.
PMID: 39583120
PMC: 11405120.
DOI: 10.1055/s-0044-1790558.
Shen S, Wang P, Wu P, Huang P, Chi T, Xu W
Mol Ther. 2024; 32(11):3974-3989.
PMID: 39245939
PMC: 11573616.
DOI: 10.1016/j.ymthe.2024.09.008.
Lu G, Shivalila C, Monian P, Yu H, Harding I, Briem S
Nucleic Acids Res. 2024; 52(17):10068-10084.
PMID: 39149897
PMC: 11417349.
DOI: 10.1093/nar/gkae681.
Evaluation of DNA minicircles for delivery of adenine and cytosine base editors using activatable gene on "GO" reporter imaging systems.
Evans M, Liu S, Krautner J, Seguin C, Leung R, Ronald J
Mol Ther Nucleic Acids. 2024; 35(3):102248.
PMID: 39040503
PMC: 11260848.
DOI: 10.1016/j.omtn.2024.102248.
Gene therapy for inherited retinal diseases: exploiting new tools in genome editing and nanotechnology.
Carvalho C, Lemos L, Antas P, Seabra M
Front Ophthalmol (Lausanne). 2024; 3:1270561.
PMID: 38983081
PMC: 11182192.
DOI: 10.3389/fopht.2023.1270561.
Engineering strategies to safely drive CAR T-cells into the future.
Rossi M, Breman E
Front Immunol. 2024; 15:1411393.
PMID: 38962002
PMC: 11219585.
DOI: 10.3389/fimmu.2024.1411393.
Expanding RNA editing toolkit using an IDR-based strategy.
Di M, Lv J, Jing Z, Yang Y, Yan K, Wu J
Mol Ther Nucleic Acids. 2024; 35(2):102190.
PMID: 38721279
PMC: 11077028.
DOI: 10.1016/j.omtn.2024.102190.
Genome editing: An insight into disease resistance, production efficiency, and biomedical applications in livestock.
Yuan Y, Liu S, Farhab M, Lv M, Zhang T, Cao S
Funct Integr Genomics. 2024; 24(3):81.
PMID: 38709433
DOI: 10.1007/s10142-024-01364-5.
A genome-scale approach for determining the function of phosphorylation sites.
Nat Methods. 2024; 21(6):940-941.
PMID: 38689100
DOI: 10.1038/s41592-024-02264-z.
Post-translational modification-centric base editor screens to assess phosphorylation site functionality in high throughput.
Kennedy P, Alborzian Deh Sheikh A, Balakar M, Jones A, Olive M, Hegde M
Nat Methods. 2024; 21(6):1033-1043.
PMID: 38684783
PMC: 11804830.
DOI: 10.1038/s41592-024-02256-z.
Deconstructing cancer with precision genome editing.
Johnson G, Gould S, Sanchez-Rivera F
Biochem Soc Trans. 2024; 52(2):803-819.
PMID: 38629716
PMC: 11088927.
DOI: 10.1042/BST20230984.
Precise genome-editing in human diseases: mechanisms, strategies and applications.
Zheng Y, Li Y, Zhou K, Li T, VanDusen N, Hua Y
Signal Transduct Target Ther. 2024; 9(1):47.
PMID: 38409199
PMC: 10897424.
DOI: 10.1038/s41392-024-01750-2.
Applications of CRISPR technologies to the development of gene and cell therapy.
Park C, Habib O, Lee Y, Hur J
BMB Rep. 2024; 57(1):2-11.
PMID: 38178651
PMC: 10828430.
Recent Therapeutic Progress and Future Perspectives for the Treatment of Hearing Loss.
Lye J, Delaney D, Leith F, Sardesai V, McLenachan S, Chen F
Biomedicines. 2023; 11(12).
PMID: 38137568
PMC: 10741758.
DOI: 10.3390/biomedicines11123347.
Shuttle peptide delivers base editor RNPs to rhesus monkey airway epithelial cells in vivo.
Kulhankova K, Traore S, Cheng X, Benk-Fortin H, Hallee S, Harvey M
Nat Commun. 2023; 14(1):8051.
PMID: 38052872
PMC: 10698009.
DOI: 10.1038/s41467-023-43904-w.
SNHG3/WISP2 Axis Promotes Hela Cell Migration and Invasion Activating Wnt/β-Catenin Signaling.
Xu D, Feng H, Ren Z, Li X, Jiang C, Chen Y
Cancer Genomics Proteomics. 2023; 20(6suppl):744-753.
PMID: 38035707
PMC: 10687733.
DOI: 10.21873/cgp.20421.
Gene and Cellular Therapies for Leukodystrophies.
Aerts-Kaya F, van Til N
Pharmaceutics. 2023; 15(11).
PMID: 38004502
PMC: 10675548.
DOI: 10.3390/pharmaceutics15112522.
Continuous directed evolution of a compact CjCas9 variant with broad PAM compatibility.
Schmidheini L, Mathis N, Marquart K, Rothgangl T, Kissling L, Bock D
Nat Chem Biol. 2023; 20(3):333-343.
PMID: 37735239
PMC: 7616171.
DOI: 10.1038/s41589-023-01427-x.